HOME | DEUTSCH | CONTACT | SITEMAP | IMPRINT
ABOUT | NEWS | PRODUCTS | TECHNOLOGY | INVESTOR RELATIONS | CAREER
PRESS RELEASES
2010
2009
2008
2007
2006
2005
CORPORATE CALENDAR
MOLOGEN AG receives approval for clinical study with cancer drug MGN1703
the press release the ad-hoc announcement
MOLOGEN: Successful capital increase completed as planned
Mr. Joerg Petrass
Dr. Matthias Schroff
Ms. Arlett Killat
To subscribe to our Newsletter please
click here
To view our Reports
TOP OF PAGE | HOME | IMPRINT | DISCLAIMER
PRESS
RELEASES 
